Back to top

Noven Pharmaceuticals, Inc. Nonqualified Deferred Compensation Plan

Executive Compensation Plan Agreement

Noven Pharmaceuticals, Inc. Nonqualified Deferred Compensation Plan | Document Parties: NOVEN PHARMACEUTICALS INC You are currently viewing:
This Executive Compensation Plan Agreement involves

NOVEN PHARMACEUTICALS INC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: Noven Pharmaceuticals, Inc. Nonqualified Deferred Compensation Plan
Governing Law: Florida     Date: 3/13/2009
Industry: Biotechnology and Drugs     Sector: Healthcare

Noven Pharmaceuticals, Inc. Nonqualified Deferred Compensation Plan, Parties: noven pharmaceuticals inc
50 of the Top 250 law firms use our Products every day

Exhibit 10.29

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
Master Plan Document

 

Effective January 1, 2006

As Amended and Restated November 18, 2008

 


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
          
Master Plan Document

 

TABLE OF CONTENTS

 

 

 

 

 

 

 

 

 

Page

 

 

 

 

 

ARTICLE 1

 

Definitions

 

1

 

 

 

 

 

ARTICLE 2

 

Selection, Enrollment, Eligibility

 

10

 

 

 

 

 

2.1

 

Selection by Committee

 

10

2.2

 

Enrollment and Eligibility Requirements; Commencement of Participation

 

10

 

 

 

 

 

ARTICLE 3

 

Deferral Commitments/Company Contribution Amounts/Company Restoration

 

 

 

 

Matching Amounts/Restricted Stock Amounts /Vesting/Crediting/Taxes

 

11

 

 

 

 

 

3.1

 

[Intentionally Omitted]

 

11

3.2

 

Maximum Deferral

 

11

3.3

 

Election to Defer; Effect of Election Form

 

12

3.4

 

Withholding and Crediting of Annual Deferral Amounts

 

13

3.5

 

Company Contribution Amount

 

14

3.6

 

Company Restoration Matching Amount

 

14

3.7

 

Restricted Stock Amount

 

14

3.8

 

Crediting of Amounts after Benefit Distribution

 

15

3.9

 

Vesting

 

15

3.10

 

Crediting/Debiting of Account Balances

 

16

3.11

 

FICA and Other Taxes

 

18

 

 

 

 

 

ARTICLE 4

 

Scheduled Distribution; Unforeseeable Emergencies

 

19

 

 

 

 

 

4.1

 

Scheduled Distribution

 

19

4.2

 

Postponing Scheduled Distributions

 

19

4.3

 

Other Benefits Take Precedence Over Scheduled Distributions

 

20

4.4

 

Unforeseeable Emergencies

 

20

 

 

 

 

 

ARTICLE 5

 

Change In Control Benefit

 

21

 

 

 

 

 

5.1

 

Change in Control Benefit

 

21

5.2

 

Payment of Change in Control Benefit

 

21

 

 

 

 

 

ARTICLE 6

 

Retirement Benefit

 

22

 

 

 

 

 

6.1

 

Retirement Benefit

 

22

6.2

 

Payment of Retirement Benefit

 

22

 

 

 

 

 

ARTICLE 7

 

Termination Benefit

 

23

 

 

 

 

 

7.1

 

Termination Benefit

 

23

7.2

 

Payment of Termination Benefit

 

23

-i-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
          
Master Plan Document

 

 

 

 

 

 

 

 

 

 

Page

 

 

 

 

 

ARTICLE 8

 

Disability Benefit

 

24

 

 

 

 

 

8.1

 

Disability Benefit

 

24

8.2

 

Payment of Disability Benefit

 

24

 

 

 

 

 

ARTICLE 9

 

Death Benefit

 

24

 

 

 

 

 

9.1

 

Death Benefit

 

24

9.2

 

Payment of Death Benefit

 

24

 

 

 

 

 

ARTICLE 10

 

Beneficiary Designation

 

24

 

 

 

 

 

10.1

 

Beneficiary

 

24

10.2

 

Beneficiary Designation; Change; Spousal Consent

 

25

10.3

 

Acknowledgement

 

25

10.4

 

No Beneficiary Designation

 

25

10.5

 

Doubt as to Beneficiary

 

25

10.6

 

Discharge of Obligations

 

25

 

 

 

 

 

ARTICLE 11

 

Leave of Absence

 

26

 

 

 

 

 

11.1

 

Paid Leave of Absence

 

26

11.2

 

Unpaid Leave of Absence

 

26

11.3

 

Leaves Resulting in Separation from Service

 

26

 

 

 

 

 

ARTICLE 12

 

Termination of Plan, Amendment or Modification

 

26

 

 

 

 

 

12.1

 

Termination of Plan

 

26

12.2

 

Amendment

 

27

12.3

 

Plan Agreement

 

27

12.4

 

Effect of Payment

 

27

 

 

 

 

 

ARTICLE 13

 

Administration

 

28

 

 

 

 

 

13.1

 

Committee Duties

 

28

13.2

 

Administration Upon Change In Control

 

28

13.3

 

Agents

 

28

13.4

 

Binding Effect of Decisions

 

28

13.5

 

Indemnity of Committee

 

28

13.6

 

Employer Information

 

28

 

 

 

 

 

ARTICLE 14

 

Other Benefits and Agreements

 

29

 

 

 

 

 

14.1

 

Coordination with Other Benefits

 

29

 

 

 

 

 

-ii-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
          
Master Plan Document

 

 

 

 

 

 

 

 

 

 

Page

 

 

 

 

 

ARTICLE 15

 

Claims Procedures

 

29

 

 

 

 

 

15.1

 

Presentation of Claim

 

29

15.2

 

Notification of Decision

 

29

15.3

 

Review of a Denied Claim

 

30

15.4

 

Decision on Review

 

30

15.5

 

Legal Action

 

31

 

 

 

 

 

ARTICLE 16

 

Trust

 

31

 

 

 

 

 

16.1

 

Establishment of the Trust

 

31

16.2

 

Interrelationship of the Plan and the Trust

 

31

16.3

 

Distributions From the Trust

 

31

 

 

 

 

 

ARTICLE 17

 

Miscellaneous

 

31

 

 

 

 

 

17.1

 

Status of Plan

 

31

17.2

 

Unsecured General Creditor

 

31

17.3

 

Employer’s Liability

 

32

17.4

 

Nonassignability

 

32

17.5

 

Not a Contract of Employment

 

32

17.6

 

Furnishing Information

 

32

17.7

 

Terms

 

32

17.8

 

Captions

 

32

17.9

 

Governing Law

 

32

17.10

 

Notice

 

32

17.11

 

Successors

 

33

17.12

 

Spouse’s Interest

 

33

17.13

 

Validity

 

33

17.14

 

Incompetent

 

33

17.15

 

Domestic Relations Orders

 

33

17.16

 

Distribution in the Event of Income Inclusion Under Code Section 409A

 

33

17.17

 

Deduction Limitation on Benefit Payments

 

34

17.18

 

Insurance

 

34

-iii-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

NOVEN PHARMACEUTICALS, INC.
NONQUALIFIED DEFERRED COMPENSATION PLAN

Effective January 1, 2006
Amended and Restated September 15, 2006
Amended and Restated November 18, 2008

Purpose

     The purpose of this Plan is to provide specified benefits to Directors and a select group of management or highly compensated Employees who contribute materially to the continued growth, development and future business success of Noven Pharmaceuticals, Inc., a Delaware corporation, and its subsidiaries, if any, that sponsor this Plan. This Plan shall be unfunded for tax purposes and for purposes of Title I of ERISA.

     The Plan is intended to comply with all applicable law, including Code Section 409A and related Treasury guidance and Regulations, and shall be operated and interpreted in accordance with this intention. This Plan was adopted effective January 1, 2006 and has been amended and restated as of September 15, 2006 and again as of November 18, 2008 to reflect certain changes necessitated by Treasury Regulations promulgated pursuant to Code Section 409A.

ARTICLE 1
Definitions

     For the purposes of this Plan, unless otherwise clearly apparent from the context, the following phrases or terms shall have the following indicated meanings:

1.1

 

“Account Balance” shall mean, with respect to a Participant, an entry on the records of the Employer equal to the sum of (i) the Deferral Account balance, (ii) the Company Contribution Account balance, (iii) the Company Restoration Matching Account balance, and (iv) the Restricted Stock Account balance. The Account Balance shall be a bookkeeping entry only and shall be utilized solely as a device for the measurement and determination of the amounts to be paid to a Participant, or his or her designated Beneficiary, pursuant to this Plan.

 

 

 

      If a Participant is both an Employee and a Director and participates in the Plan in each capacity, then separate Account Balances shall be established for such Participant as a device for the measurement and determination of the (a) amounts deferred under the Plan that are attributable to the Participant’s status as an Employee, and (b) amounts deferred under the Plan that are attributable to the Participant’s status as a Director.

 

1.2

 

“Annual Deferral Amount” shall mean that portion of a Participant’s Base Salary, Bonus, Director Fees and LTIP Amounts that a Participant defers in accordance with Article 3 for any one Plan Year, without regard to whether such amounts are withheld and credited

-1-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

 

 

during such Plan Year. In the event of a Participant’s Retirement, Disability, death or Termination of Employment prior to the end of a Plan Year, such year’s Annual Deferral Amount shall be the actual amount withheld prior to such event.

 

1.3

 

“Annual Installment Method” shall be an annual installment payment over the number of years selected by the Participant in accordance with this Plan, calculated as follows: (i) for the first annual installment, the Participant’s vested Account Balance shall be calculated as of the close of business on or around the Participant’s Benefit Distribution Date, as determined by the Committee in its sole discretion, and (ii) for remaining annual installments, the Participant’s vested Account Balance shall be calculated on every anniversary of such calculation date, as applicable. Each annual installment shall be calculated by multiplying this balance by a fraction, the numerator of which is one and the denominator of which is the remaining number of annual payments due the Participant. By way of example, if the Participant elects a ten (10) year Annual Installment Method for the Retirement Benefit, the first payment shall be 1/10 of the vested Account Balance, calculated as described in this definition. The following year, the payment shall be 1/9 of the vested Account Balance, calculated as described in this definition. Shares of Stock that shall be distributable from the Restricted Stock Account shall be distributable in shares of actual Stock in the same manner previously described. However, the Committee may, in its sole discretion, adjust the annual installments in order to distribute whole shares of actual Stock .

 

1.4

 

“Base Salary” shall mean the annual cash compensation relating to services performed during any calendar year, excluding distributions from nonqualified deferred compensation plans, bonuses, commissions, overtime, fringe benefits, stock options, relocation expenses, incentive payments, non-monetary awards, director fees and other fees, and automobile and other allowances paid to a Participant for employment services rendered (whether or not such allowances are included in the Employee’s gross income). Base Salary shall be calculated before reduction for compensation voluntarily deferred or contributed by the Participant pursuant to all qualified or nonqualified plans of any Employer and shall be calculated to include amounts not otherwise included in the Participant’s gross income under Code Sections 125, 402(e)(3), 402(h), or 403(b) pursuant to plans established by any Employer; provided, however, that all such amounts will be included in compensation only to the extent that had there been no such plan, the amount would have been payable in cash to the Employee.

 

1.5

 

“Beneficiary” shall mean one or more persons, trusts, estates or other entities, designated in accordance with Article 10, that are entitled to receive benefits under this Plan upon the death of a Participant.

 

1.6

 

“Beneficiary Designation Form” shall mean the form established from time to time by the Committee that a Participant completes, signs and returns to the Committee to designate one or more Beneficiaries.

 

1.7

 

“Benefit Distribution Date” shall mean the date that triggers distribution of a Participant’s vested Account Balance. A Participant’s Benefit Distribution Date shall be determined upon the occurrence of any one of the following:

-2-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

 

(a)

 

If the Participant Retires, his or her Benefit Distribution Date shall be

 

(i)

 

the last day of the six-month period immediately following the date on which the Participant Retires if the Participant is a Key Employee, and

 

 

(ii)

 

for all other Participants, the date on which the Participant Retires;

 

 

(iii)

 

provided, however , in the event the Participant changes his or her Retirement Benefit election in accordance with Section 6.2(b), his or her Benefit Distribution Date shall be postponed in accordance with Section 6.2(b); or

 

 

(b)

 

If the Participant experiences a Termination of Employment, his or her Benefit Distribution Date shall be

 

(i)

 

the last day of the six-month period immediately following the date on which the Participant experiences a Termination of Employment if the Participant is a Key Employee, and

 

 

(ii)

 

for all other Participants, the date on which the Participant experiences a Termination of Employment;

 

 

(iii)

 

provided, however , in the event the Participant changes his or her Termination Benefit election in accordance with Section 7.2(b), his or her Benefit Distribution Date shall be postponed in accordance with Section 7.2(b); or

 

 

(c)

 

The date on which the Committee is provided with proof that is satisfactory to the Committee of the Participant’s death, if the Participant dies prior to the complete distribution of his or her vested Account Balance; or

 

 

(d)

 

The date on which the Participant becomes Disabled; or

 

 

(e)

 

The date on which the Company experiences a Change in Control, as determined by the Committee in its sole discretion, if (i) the Participant has elected to receive a Change in Control Benefit, as set forth in Section 5.1 below, and (ii) if a Change in Control occurs prior to the Participant’s Termination of Employment, Retirement, death or Disability.

1.8

 

“Board” shall mean the board of directors of the Company.

 

1.9

 

“Bonus” shall mean any compensation, in addition to Base Salary and LTIP Amounts, earned by a Participant for services rendered during a Plan Year, under any Employer’s annual bonus and cash incentive plans, or other arrangement designated by the Committee, as further specified on an Election Form.

 

1.10

 

“Change in Control” shall mean any “change in control event” as defined in accordance with Code Section 409A and related Treasury guidance and Regulations; provided that for purposes of Treas. Reg. §1.409A-3(i)(5)(vi)(A)(1), a 40 percent threshold shall be used.

-3-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

1.11

 

“Change in Control Benefit” shall have the meaning set forth in Article 5.

 

1.12

 

“Claimant” shall have the meaning set forth in Section 15.1.

 

1.13

 

“Code” shall mean the Internal Revenue Code of 1986, as it may be amended from time to time.

 

1.14

 

“Committee” shall mean the committee described in Article 13.

 

1.15

 

“Company” shall mean Noven Pharmaceuticals, Inc., a Delaware corporation, and any successor to all or substantially all of the Company’s assets or business.

 

1.16

 

“Company Contribution Account” shall mean (i) the sum of the Participant’s Company Contribution Amounts, plus (ii) amounts credited or debited to the Participant’s Company Contribution Account in accordance with this Plan, less (iii) all distributions made to the Participant or his or her Beneficiary pursuant to this Plan that relate to the Participant’s Company Contribution Account.

 

1.17

 

“Company Contribution Amount” shall mean, for any one Plan Year, the amount determined in accordance with Section 3.5.

 

1.18

 

“Company Restoration Matching Account” shall mean (i) the sum of all of a Participant’s Company Restoration Matching Amounts, plus (ii) amounts credited or debited to the Participant’s Company Restoration Matching Account in accordance with this Plan, less (iii) all distributions made to the Participant or his or her Beneficiary pursuant to this Plan that relate to the Participant’s Company Restoration Matching Account.

 

1.19

 

“Company Restoration Matching Amount” shall mean, for any one Plan Year, the amount determined in accordance with Section 3.6.

 

1.20

 

“Death Benefit” shall mean the benefit set forth in Article 9.

 

1.21

 

“Deferral Account” shall mean (i) the sum of all of a Participant’s Annual Deferral Amounts, plus (ii) amounts credited or debited to the Participant’s Deferral Account in accordance with this Plan, less (iii) all distributions made to the Participant or his or her Beneficiary pursuant to this Plan that relate to his or her Deferral Account.

 

1.22

 

“Director” shall mean any elected or appointed member of the board of directors of any Employer.

 

1.23

 

“Director Fees” shall mean the annual fees payable in cash that are earned by a Director from any Employer, including retainer fees and meetings fees, as compensation for serving on the board of directors.

 

1.24

 

“Disability” or “Disabled” shall mean that a Participant is (i) unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a

-4-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

 

 

continuous period of not less than 12 months, or (ii) by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than 3 months under an accident or health plan covering employees of the Participant’s Employer. For purposes of this Plan, a Participant shall be deemed Disabled if determined to be totally disabled by the Social Security Administration, or if determined to be disabled in accordance with the applicable disability insurance program of such Participant’s Employer, provided that the definition of “disability” applied under such disability insurance program complies with the requirements in the preceding sentence.

 

1.25

 

“Disability Benefit” shall mean the benefit set forth in Article 8.

 

1.26

 

“Election Form” shall mean the form, which may be in electronic format, established from time to time by the Committee that a Participant completes, signs and returns to the Committee to make an election under the Plan.

 

1.27

 

“Employee” shall mean a person who is an employee of any Employer.

 

1.28

 

“Employer(s)” shall be defined as follows:

 

(a)

 

Except as otherwise provided in part (b) of this Section, the term “Employer” shall mean the Company and/or any of its subsidiaries (now in existence or hereafter formed or acquired) that have been selected by the Board to participate in the Plan and have adopted the Plan as a sponsor.

 

 

(b)

 

For purposes of determining whether a Participant has experienced a Separation from Service, the term “Employer” shall mean:

 

 

(i)

 

The entity for which the Participant performs services and with respect to which the legally binding right to compensation deferred or contributed under this Plan arises; and

 

 

(ii)

 

All other entities with which the entity described above would be aggregated and treated as a single employer under Code Section 414(b)(controlled group of corporations) and Code Section 414(c)(a group of trades or businesses, whether or not incorporated, under common control), as applicable. In order to identify the group of entities described in the preceding sentence, the Committee shall use an ownership threshold of at least 50% as a substitute of the 80% minimum ownership threshold that appears in, and otherwise must be used when applying, the applicable provisions of (A) Code Section 1563 for determining a controlled group of corporations under Code Section 414(b), and Treas. Reg. §1.414(c)-2 for determining the trades or businesses that are under common control under Code Section 414(c).

-5-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

1.29

 

“ERISA” shall mean the Employee Retirement Income Security Act of 1974, as it may be amended from time to time.

 

1.30

 

“401(k) Plan” shall mean, with respect to an Employer, a plan qualified under Code Section 401(a) that contains a cash or deferral arrangement described in Code Section 401(k), adopted by the Employer, as it may be amended from time to time, or any successor thereto.

 

1.31

 

“Key Employee” shall mean any Participant who is a “key employee” (as defined in Code Section 416(i) without regard to paragraph (5) thereof) of an Employer whose stock is publicly traded on an established securities market or otherwise, as determined by the Committee based upon the 12-month period ending on each December 31 st (such 12-month period is referred to below as the “identification period”). In applying the applicable provisions of Code Section 416(i) to identify such individuals, “compensation” shall be determined in accordance with Treas. Reg. §1.415(c)-2(a) without regard to (i) any safe harbor provided in Treas. Reg. §1.415(c)-2(d), (ii) any of the special timing rules provided in Treas. Reg. §1.415(c)-2(e), and (iii) any of the special rules provided in Treas. Reg. §1.415(c)-2(g). All Participants who are determined to be key employees under Code Section 416(i) (without regard to paragraph (5) thereof) during the identification period shall be treated as Key Employees for purposes of the Plan during the 12-month period that begins on the first day of the 4 th month following the close of such identification period.

 

1.32

 

“LTIP Amounts” shall mean any portion of the cash compensation attributable to a Plan Year that is earned by a Participant as an Employee under any Employer’s long-term incentive plan or any other long-term incentive arrangement designated by the Committee.

 

1.33

 

“Participant” shall mean any Employee or Director (i) who is selected to participate in the Plan, (ii) who submits an executed Plan Agreement, Election Form and Beneficiary Designation Form, which are accepted by the Committee, and (iii) whose Plan Agreement has not terminated.

 

1.34

 

“Performance-Based Compensation” shall mean compensation the entitlement to or amount of which is contingent on the satisfaction of pre-established organizational or individual performance criteria relating to a performance period of at least 12 consecutive months, as determined by the Committee in accordance with Treas. Reg. §1.409A-1(e).

 

1.35

 

“Plan” shall mean the Noven Pharmaceuticals, Inc. Nonqualified Deferred Compensation Plan, which shall be evidenced by this instrument and any Plan Agreement, as they may be amended from time to time, and by any other documents that together with this instrument define a Participant’s rights to amounts credited to his or her Account Balance.

 

1.36

 

“Plan Agreement” shall mean a written agreement, as may be amended from time to time, which is entered into by and between an Employer and a Participant. Each Plan Agreement executed by a Participant and the Participant’s Employer shall provide for the entire benefit to which such Participant is entitled under the Plan; should there be more than one Plan Agreement, the Plan Agreement bearing the latest date of acceptance by the Employer shall supersede all previous Plan Agreements in their entirety and shall govern such entitlement. The terms of any Plan Agreement may be different for any Participant, and any Plan Agreement may provide additional

-6-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

 

 

benefits not set forth in the Plan or limit the benefits otherwise provided under the Plan; provided, however, that any such additional benefits or benefit limitations must be agreed to by both the Employer and the Participant.

 

1.37

 

“Plan Year” shall mean a period beginning on January 1 of each calendar year and continuing through December 31 of such calendar year.

 

1.38

 

“Restricted Stock” shall mean rights to receive unvested shares of restricted stock selected by the Committee in its sole discretion and awarded to the Participant under any Noven Pharmaceuticals, Inc. stock incentive plan or director compensation program.

 

1.39

 

“Restricted Stock Account” shall mean the aggregate value, measured on any given date, of (i) the number of shares of Restricted Stock deferred by a Participant as a result of all Restricted Stock Amounts, plus (ii) the number of additional shares credited to a Participant’s Restricted Stock Account as a result of the deemed reinvestment of dividends in accordance with this Plan, less (iii) the number of shares of Restricted Stock previously distributed to the Participant or his or her Beneficiary pursuant to this Plan, subject in each case to any adjustments to the number of such shares determined by the Committee with respect to the Noven Pharmaceuticals, Inc. Stock Unit Fund pursuant to Section 3.10. This portion of the Participant’s Account Balance shall only be distributable in actual shares of Stock.

 

1.40

 

“Restricted Stock Amount” shall mean, with respect to a Participant for any one Plan Year, the amount of Restricted Stock deferred in accordance with Section 3.7 of this Plan, calculated using the closing price of Stock at the end of the business day closest to the date such Restricted Stock would otherwise vest (and/or all restrictions on such Restricted Stock would have lapsed), but for the election to defer. In the event of a Participant’s Retirement, Termination of Employment, Disability, or death prior to the end of a Plan Year, such year’s Restricted Stock Amount shall be the actual amount withheld prior to such event.

 

1.41

 

“Retirement”, “Retire(s)” or “Retired” shall mean, with respect to a Participant who is an Employee, a Separation from Service on or after the earlier of the attainment of (a) age sixty-five (65) or (b) age fifty-five (55) with five (5) Years of Service; and shall mean with respect to a Participant who is a Director, a Separation from Service. If a Participant is both an Employee and a Director and participates in the Plan in each capacity, (a) the determination of whether the Participant qualifies for Retirement as an Employee shall be made when the Employee experiences a Separation from Service as an Employee and such determination shall only apply to the applicable Account Balance established in accordance with Section 1.1 for amounts deferred under the Plan as an Employee, and (b) the determination of whether the Participant qualifies for Retirement as a Director shall be made at the time the Participant experiences a Separation from Service as a Director and such determination shall apply only to the applicable Account Balance established in accordance with Section 1.1. for amounts deferred under the Plan as a Director.

 

1.42

 

“Retirement Benefit” shall mean the benefit set forth in Article 6.

-7-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

1.43

 

“Separation from Service” shall mean a termination of services provided by a Participant to his or her Employer, whether voluntary or involuntary, other than by reason of death or Disability, as determined by the Committee in accordance with Treas. Reg. §1.409A-1(h). In determining whether a Participant has experienced a Separation from Service the following provisions shall apply:

 

(a)

 

For a Participant who provides services to an Employer as an Employee, except as otherwise provides in part (c) of this Section, a Separation from Service shall occur when such Participant has experienced a termination of employment with such Employer, A Participant shall be considered to have experienced a termination of employment when the facts and circumstances indicate that the Participant and his or her Employer reasonably anticipate that either (i) no further services will be performed for the Employer after a certain date, or (ii) that the level of bona fide services the Participant will perform for the Employer after such date (whether as an Employee or as an independent contractor) will permanently decrease to no more than 20% of the average level of bona fide services performed by such Participant (whether as an Employee or an independent contractor) over the immediately preceding 36-month period (or the full period of services to the Employer if the Participant has been providing services to the Employer less than 36 months).

 

 

 

 

      If a Participant is on military leave, sick leave, or other bona fide leave of absence, the employment relationship between the Participant and the Employer shall be treated as continuing in tact, provided that the period of such leave does not exceed 6 months, or if longer, so long as the Participant retains a right to reemployment with the Employer under an applicable statute or contract. If the period of a military leave, sick leave, or other bona fide leave of absence exceeds 6 months and the Participant does not retain a right to reemployment under an applicable statute or by contract, the employment relationship shall be considered to be terminated for purposes of this Plan as of the first day immediately following the end of such 6-month period. In applying the provisions of this paragraph, a leave of absence shall be considered a bona fide leave of absence only if there is a reasonable expectation that the Participant will return to perform services for the Employer.

 

 

(b)

 

For a Participant who provides services to an Employer as an independent contractor, except as otherwise provided in part (c) of this Section, a Separation from Service shall occur upon the expiration of the contract (or in the case of more than one contract, all contracts) under which services are performed for such Employer, provided that the expiration of such contract(s) is determined by the Committee to constitute a good-faith and complete termination of the contractual relationship between the Participant and such employer.

 

 

(c)

 

For a Participant who provides services to an Employer as both an Employee and an independent contractor, a Separation from Service generally shall not occur until the Participant has ceased providing services for such Employer as both an Employee and

-8-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

 

 

 

an independent contractor, as determined in accordance with the provisions set forth in parts (a) and (b) of this section, respectively. Similarly, if a Participant either (i) ceases providing services for an Employer as an independent contractor and begins providing services for such Employer as an Employee, or (ii) ceases providing services for an Employer as an Employee and begins providing services for such Employer as an independent contractor, the Participant will not be considered to have experienced a Separation from Service until the Participant has ceased providing services for such Employer in both capacities, as determined in accordance with the applicable provisions set forth in parts (a) and (b) of this Section.

 

 

 

 

      Notwithstanding the foregoing provisions in this part (c), if a Participant provides services for an Employer as both an Employee and as a Director, to the extent permitted by Treas. Reg. §1.409A-1(h)(5) the services provided by such Participant as a Director shall not be taken into account in determining whether the Participant has experienced a Separation from Service as an Employee, and the services provided by such Participant as an Employee shall not be taken into account in determining whether the Participant has experienced a Separation from Service as a Director.

1.44

 

“Scheduled Distribution” shall mean the distribution set forth in Section 4.1.

 

1.45

 

“Stock” shall mean Noven Pharmaceuticals, Inc. common stock, $0.0001 par value, or any other equity securities of the Company designated by the Committee.

 

1.46

 

“Terminate the Plan”, “Termination of the Plan” shall mean a determination by an Employer’s board of directors that (i) all of its Participants shall no longer be eligible to participate in the Plan, (ii) no new deferral elections for such Participants shall be permitted, and (iii) such Participants shall no longer be eligible to receive company contributions under this Plan.

 

1.47

 

“Termination Benefit” shall mean the benefit set forth in Article 7.

 

1.48

 

“Termination of Employment” shall mean the separation from service with all Employers, voluntarily or involuntarily, for any reason other than Retirement, Disability or death, as determined in accordance with Code Section 409A and related Treasury guidance and Regulations. If a Participant is both an Employee and a Director, a Termination of Employment shall occur only upon the termination of the last position held. A Participant will not have a Termination of Employment unless the Participant is not employed by the Company, a Subsidiary, or any other member of the Controlled Group of Corporations as defined under Code Section 414(b) (dealing with controlled groups of corporations) and Code Section 414(c), regardless of the reason for the termination of employment.

 

1.49

 

“Trust” shall mean one or more trusts established by the Company in accordance with Article 16.

 

1.50

 

“Unforeseeable Emergency” shall mean a severe financial hardship of the Participant resulting from (i) an illness or accident of the Participant, the Participant’s spouse, the Participant’s Beneficiary or the Participant’s dependent (as defined in Code Section 152(a)

-9-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

 

 

without regard to paragraphs (b)(1), (b)(2) and (d)(1)(b) thereof), (ii) a loss of the Participant’s property due to casualty, or (iii) such other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant, all as determined by the Committee based on the relevant facts and circumstances.

 

1.51

 

“Years of Service” shall mean the total number of full years in which a Participant has been employed by one or more Employers. For purposes of this definition, a year of employment shall be a 365 day period (or 366 day period in the case of a leap year) that, for the first year of employment, commences on the Employee’s date of hiring and that, for any subsequent year, commences on an anniversary of that hiring date. The Committee shall make a determination as to whether any partial year of employment shall be counted as a Year of Service.

ARTICLE 2
Selection, Enrollment, Eligibility

2.1

 

Selection by Committee . Participation in the Plan shall be limited to Directors and, as determined by the Committee in its sole discretion, a select group of management or highly compensated Employees. From that group, the Committee shall select, in its sole discretion, those individuals who may actually participate in this Plan.

 

2.2

 

Enrollment and Eligibility Requirements; Commencement of Participation .

 

(a)

 

As a condition to participation, each Director or selected Employee who is eligible to participate in the Plan effective as of the first day of a Plan Year shall complete, execute and return to the Committee a Plan Agreement, an Election Form and a Beneficiary Designation Form, prior to the first day of such Plan Year, or such other earlier deadline as may be established by the Committee in its sole discretion. In addition, the Committee shall establish from time to time such other enrollment requirements as it determines, in its sole discretion, are necessary.

 

 

(b)

 

A Director or selected Employee who first becomes eligible to participate in this Plan after the first day of a Plan Year must complete, execute and return to the Committee a Plan Agreement, an Election Form, and a Beneficiary Designation Form within thirty (30) days after he or she first becomes eligible to participate in the Plan, or within such other earlier deadline as may be established by the Committee, in its sole discretion, in order to participate for that Plan Year. In such event, such person’s participation in this Plan shall not commence earlier than the date determined by the Committee pursuant to Section 2.2(c) and such person shall not be permitted to defer under this Plan any portion of his or her Base Salary, Bonus, LTIP Amounts, Restricted Stock Amounts and/or Director Fees that are paid with respect to services performed prior to his or her participation commencement date, except to the extent permissible under Code Section 409A and related Treasury guidance or Regulations.

-10-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

 

(c)

 

Each Director or selected Employee who is eligible to participate in the Plan shall commence participation in the Plan on the date that the Committee determines, in its sole discretion, that the Director or Employee has met all enrollment requirements set forth in this Plan and required by the Committee, including returning all required documents to the Committee within the specified time period. Notwithstanding the foregoing, the Committee shall process such Participant’s deferral election as soon as administratively practicable after such deferral election is submitted to and accepted by the Committee.

 

 

(d)

 

If a Director or an Employee fails to meet all requirements contained in this Section 2.2 within the period required, that Director or Employee shall not be eligible to participate in the Plan during such Plan Year.

ARTICLE 3
Deferral Commitments/Company Contribution Amounts/
Company Restoration Matching Amounts/Restricted Stock Amounts/
Vesting/Crediting/Taxes

3.1

 

[Intentionally Omitted]

 

3.2

 

Maximum Deferral .

 

(a)

 

Annual Deferral Amount . For each Plan Year, a Participant may elect to defer, as his or her Annual Deferral Amount, Base Salary, Bonus, LTIP Amounts and/or Director Fees up to the following maximum percentages for each deferral elected:

 

 

 

 

 

 

Deferral

 

Maximum Percentage

 

Base Salary

 

 

75

%

Bonus

 

 

100

%

LTIP Amounts

 

 

100

%

Director Fees

 

 

100

%

 

 

(b)

 

Restricted Stock Amount . For each grant of Restricted Stock, a Participant may elect to defer, as his or her Restricted Stock Amount, Restricted Stock in the following maximum percentage:

 

 

 

 

 

Deferral

 

Maximum Percentage

 

Restricted Stock

 

 

100

%

 

 

(c)

 

Short Plan Year . Notwithstanding the foregoing, if a Participant first becomes a Participant after the first day of a Plan Year, the maximum Annual Deferral Amount shall be limited to the amount of compensation not yet earned by the Participant as of the date the Participant submits a Plan Agreement and Election Form to the Committee for acceptance, except to the extent permissible

-11-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

 

 

 

under Code Section 409A and related Treasury guidance or Regulations. For compensation that is earned based upon a specified performance period, the Participant’s deferral election will apply to the portion of such compensation that is equal to (i) the total amount of compensation for the performance period, multiplied by (ii) a fraction, the numerator of which is the number of days remaining in the service period after the Participant’s deferral election is made, and the denominator of which is the total number of days in the performance period.

3.3

 

Election to Defer; Effect of Election Form .

 

 

 

 

     (a) General Timing Rule for Deferral Elections . Except as otherwise provided in this Section 3.3, in order for a Participant to make a valid election to defer Base Salary, Bonus, Commissions, Director Fees and/or LTIP Amounts, the Participant must submit an Election Form on or before the deadline established by the Committee, which in no event shall be later than the December 31 st preceding the Plan Year in which such compensation will be earned.

 

 

 

 

      Any deferral election made in accordance with this Section 3.3 shall be irrevocable; provided, however, that if the Committee permits or requires Participants to make a deferral election by the deadline described above for an amount that qualifies as Performance-Based Compensation, the Committee may permit a Participant to subsequently change his or her deferral election for such compensation by submitting a new Election Form in accordance with Section 3.3(d) below.

 

 

 

 

(b) Timing of Deferral Elections for Newly Eligible Plan Participants . A Director or selected Employee who first becomes eligible to participate in the Plan on or after the beginning of a Plan Year, as determined in accordance with Treas. Reg. §1.409A-2(a)(7)(ii) and the “plan aggregation” rules provided in Treas. Reg. §1.409A-1(c)(2), may be permitted to make an election to defer the portion of Base Salary, Bonus, Commissions, Director Fees and/or LTIP Amounts attributable to services to be performed after such election, provided that the Participant submits an Election Form on or before the deadline established by the Committee, which in no event shall be later than 30 days after the Participant first becomes eligible to participate in the Plan.

 

 

 

 

      If a deferral election made in accordance with this Section 3.3(b) relates to compensation earned based upon a specified performance period, the amount eligible for deferral shall be equal to (i) the total amount of compensation for the performance period, multiplied by (ii) a fraction, the numerator of which is the number of days remaining in the service period after the Participant’s deferral election is made, and the denominator of which is the total number of days in the performance period.

 

 

 

 

     Any deferral election made in accordance with this Section 3.3(b) shall become irrevocable no later than the 30 th day after the date the Director or selected Employee becomes eligible to participate in the Plan.

-12-


 

Noven Pharmaceuticals, Inc.
Nonqualified Deferred Compensation Plan
           Master Plan Document

 

 

 

 

(c) Restricted Stock Deferral . For an election to defer Restricted Stock to be valid, an Election Form must be completed and signed by the Participant with respect to such Restricted Stock. Such Election Form must be timely delivered to the Committee and accepted by the Committee no later than (i) the end of the calendar year preceding the Plan Year during which such Restricted Stock may be initially granted to the Participant under the terms of the applicable Noven Pharmaceuticals, Inc. stock incentive plan or director compensation program, or (ii) such other deadline established by the Committee in accordance with the requirements of Code Section 409A and related Treasury guidance or Regulations, including, without limitation, such deadline as may be applicable under Section 3.3(d) or Section 3.3(e) below.

 

 

 

 

(d) Performance-Based Compensation . Subject to the limitations described below, the Committee may determine that an irrevocable deferral election for an amount that qualifies as Performance-Based Compensation may be made by submitting an Election Form on or before the deadline established by the Committee, which in no event shall be later than 6 months before the end of the performance period. In order for a Participant to be eligible to make a deferral election for Performance-Based Compensation in accordance with the deadline established pursuant to this Section 3.3(d), the Participant must have performed services continuously from the later of (i) the beginning of the performance period for such compensation, or (ii) the date upon which the performance criteria for such compensation are established, through the date upon which the Participant makes the deferral election for such compensation. In no event shall a deferral election submitted under this Section 3.3(d) be permitted to apply to any amount of Performance-Based Compensation that has become readily ascertainable..

 

 

 

 

(e) Compensation Subject to Risk of For


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more